People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sancilio Pharmaceuticals Company, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2018 |
Marc Wolff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marc Wolff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Gray | 1 | 10 |
| Dennis Langer | 1 | 9 |
| Frederick Sancilio | 1 | 4 |
| GEOFFREY GLASS | 1 | 2 |
| Albert Cavagnaro | 1 | 1 |
| Jim Gale | 1 | 1 |
| Oscar Groet | 1 | 1 |
| Leandra Mollanazar | 1 | 1 |
| Thorsteinn Thorsteinsson | 1 | 1 |
| Tony Lodovico | 1 | 1 |
| John Celentano | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.